Nordic Clinical Trials
The Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) is a cohesive and extensive group of
Neuro-Ophthalmologists, other doctors, coordinators, biostatisticians, clinical trial experts and reading centers, who
have developed a structured organization to perform prospective clinical research with the support of the National Eye
Institute of the NIH, other funding agencies, and industry.
Click here to read our mission
statement
Idiopathic Intracranial Hypertension (IIH) What is IIH?
Research Study: Surgical IIH Treatment Trial (SIGHT) (more info)
Sponsor: The National Eye Institute
This NORDIC Investigator-initiated study compares medical treatment and two types of surgical treatments for IIH.
Non-Arteritic Ischemic Optic Neuropathy (NAION) What is NAION?
-
Research Study: Treatment Trial for Patients with previous, chronic NAION (more info)Sponsor: Regenera PharmaThis treatment trial will evaluate Regenera's novel drug, made from a plant extract, to treat chronic NAION.
-
Research Study: Treatment Trial for Patients with recent, acute NAION (more info)Sponsor: Quark PharmaceuticalsThis investigational drug trial will evaluate a neuroprotection therapy for acute NAION.